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Macrophages are a major target for human immunodeficiency virus type 1 (HIV-1) infec-
tion. However, macrophages are largely heterogeneous and may exhibit differences in 
permissiveness to HIV-1 infection. This study highlights the interplay of macrophage 
heterogeneity in HIV-1 pathogenesis. We show that monocyte-derived macrophages 
(MDMs) could be divided into two distinct subsets: CD14+Siglec-1hiCD4+ (non-adher-
ent MDM) and CD14+Siglec-1LoCD4− (adherent MDM). The CD14+Siglec-1hiCD4+MDM 
subset represented the smaller proportion in the macrophage pool, and varied among 
different donors. Fractionation and subsequent exposure of the two MDM subsets to 
HIV-1 revealed opposite outcomes in terms of HIV-1 capture and infection. Although 
the CD14+Siglec-1hiCD4+MDM captured significantly more HIV-1, infection was 
significantly higher in the CD14+Siglec-1LoCD4−MDM subset. Thus, CD14+Siglec-
1hiCD4+MDM were less permissive to infection. Depletion of CD14+Siglec-1hiCD4+MDM 
or a decrease in their percentage, resulted in increased infection of MDM, suggestive 
of a capacity of these cells to capture and sequester HIV-1 in an environment that 
hinders its infectivity. Increased expression of innate restriction factors and cytokine 
genes were observed in the non-adherent CD14+Siglec-1hiCD4+MDM, both before 
and after HIV-1 infection, compared to the adherent CD14+Siglec-1LoCD4−MDM. 
We speculate that the differential expression of gene expression profiles in the two 
macrophage subsets may provide an explanation for the differences observed in HIV-1 
infectivity.
Keywords: monocyte-derived macrophages, human immunodeficiency virus type 1, siglec-1, cD4, rna-seq, 
restriction factors
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inTrODUcTiOn
Macrophages are important targets of human immunodefi-
ciency virus type 1 (HIV-1) infection (1–4) and may represent 
specialized viral reservoirs, with the ability to store HIV-1 par-
ticles in intracellular compartments (5, 6). It has been reported 
that infectious HIV-1 within macrophages are protected from 
neutralizing antibodies (7), further complicating HIV-1 eradica-
tion. Due to their dissemination over different tissues and their 
capacity to infiltrate virtually all organs including the brain, 
macrophages could likely contribute to the spread of HIV-1 and 
HIV-related pathologies, including immune dysfunction, per-
sistent hyperimmune activation, and the onset of opportunistic 
infections (4, 8, 9).
In humans, macrophages arise from circulating or resident 
monocytes which are largely present in the blood, spleen and 
bone marrow. Circulating monocytes exhibit heterogeneity and 
are classified into classical monocytes, intermediate, and non-
classical monocytes. Although earlier reports defined circulat-
ing monocytes as the precursors of tissue macrophages, recent 
studies have shown that tissue macrophages with self-renewal 
properties could arise from yolk sac, liver, and bone-marrow 
independent of monocyte precursors (10–12). Therefore, cir-
culating monocytes represent only one source of tissue resident 
macrophages. The necessity of the circulating monocytes to 
repopulate macrophages in certain tissues versus the ability 
of macrophages to self renew in other tissues independent of 
circulating monocytes (13), highlights the complexity of tissue 
resident macrophage populations.
In human lungs, macrophage heterogeneity in the bronchoal-
veolar space is reflected by the presence of small and large alveolar 
macrophages, with small alveolar macrophages being more 
sus ceptible to HIV-1 infection than large alveolar macrophages 
(14). In the lungs of rhesus macaques, macrophage heterogeneity 
is exemplified by the presence of multiple macrophage popu-
lations including alveolar and interstitial macrophages (15), 
with interstitial macrophages being more permissive to simian 
immunodeficiency virus than alveolar macrophages (16).
Until recently, CD4 and chemokine receptors were the major 
cellular molecules associated with HIV-1 infection. However, 
recent studies have revealed the involvement of sialic acid-bind-
ing immunoglobulin-like lectin-1 (Siglec-1, CD169) in HIV-1 
infection of myeloid cells. Siglec-1 is an interferon-inducible 
member of the I-type lectin receptor family found on the sur-
face of dendritic cells and macrophages. In vivo, expression of 
Siglec-1 on myeloid cells is upregulated by immune activation, 
and these cells have been shown to accumulate in the CD4+ 
T cells-enriched lymphocyte tissues (17). Siglec-1 on dendritic 
cells captures HIV-1 by binding to sialyllactose-containing 
gangliosides exposed on HIV-1 membranes (18, 19). Siglec-1 
also facilitates HIV-1 infection of macrophages via its interac-
tion with sialic acid on gp120 (20, 21). It was recently reported 
that Siglec-1 mediated the accumulation of HIV-1 into virus-
containing compartments of macrophages and also mediated the 
transinfection of autologous T cells (22).
In this study, using an in vitro infection system, we identified two 
distinct macrophage subsets, CD14+Siglec-1hiCD4+CD163+MDM 
and CD14+Siglec-1LoCD4−CD163−MDM. We characterized their 
permissiveness to HIV-1 infection and their gene expression pro-
files in response to HIV-1. Our data revealed distinct differences 
in HIV-1 infectivity and anti-HIV-1 gene expression between the 
two-macrophage subsets. These results could have implications 
in the role of macrophages in HIV-1 pathogenesis.
MaTerials anD MeThODs
antibodies
The following human monoclonal antibodies (mAbs) anti-
CD11b PE (clone ICRF44), CD11b FITC (clone ICRF44), CD14 
APC (clone M5E2), CD14 PerCP (clone MoP9), CD163 FITC 
(clone GHI/61), CD4 PE (clone RPA-T4), CD3 PerCP (clone 
SK7), CD195 FITC (2D7/CCR5), and 7-amino actinomycin D 
(7-AAD) were obtained from BD Pharmingen. Anti-CD169 APC 
(clone 7-239) was obtained from BioLegend. Anti-p24-FITC and 
anti-p24-RD1 were purchased from Beckman Coulter.
Media and reagents
Media components and reagents were obtained as follows: 
RPMI-1640 (BioWhittaker), l-glutamine and penicillin/strep-
tomycin (Quality Biologicals Inc.), Accutase (eBiosciences), 
recombinant human M-CSF (PeproTech), polybrene, bovine 
serum albumin (BSA), PKH-67, and PKH-26 (Sigma-Aldrich), 
and fetal bovine serum (Gemini Bio Products). Fixation and 
permeabilization buffers (Reagents A and B) were from Caltag.
Monocyte media consisted of RPMI-1640 supplemented with 
10% heat-inactivated FBS, 1% l-glutamine, and 1% penicillin/
streptomycin. M-CSF media (monocyte media supplemented 
with 50  ng/ml M-CSF) was used for differentiating the mono-
cytes into macrophages. For infecting the macrophages, M-CSF 
media containing 2 µg/ml polybrene (Infection media) was used.
Virus Purification
HIV-1 primary subtype B viruses (US-1, BaL, and JRFL) were 
grown in peripheral blood mononuclear cells (PBMCs) from 
stocks obtained from Dr. Victoria Polonis (USMHRP). The 
primary viruses were purified as previously described (23). 
Infectivity and p24 concentration were determined before and 
after purification to ensure that infectivity was not lost during the 
purification procedure.
enrichment and In Vitro culture of 
Monocytes
Peripheral blood mononuclear cells from healthy HIV-1 
seronegative donors were isolated by Ficoll density gradient cen-
trifugation under an internal review board-approved protocol, 
RV229/WRAIR number 1386. Monocytes were enriched from 
the PBMCs by plastic adherence in 24-well plates (Corning), 
and differentiated into monocyte-derived macrophages (MDM) 
in 1  ml M-CSF media, as previously described (21). MDM 
were used on day 5 postculture for flow cytometry. For HIV-1 
infection, polybrene (2 µg/ml) was added to the MDM cultures 
during the last 30 min of the in vitro culture, before subsequent 
exposure to HIV-1.
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Fractionation of MDM
M-CSF-derived MDM cultures comprised two cell fractions—
adherent and non-adherent. The non-adherent MDM were 
isolated from their adherent counterparts by repeated gentle 
washes with monocyte media. The non-adherent MDM were 
gently aspirated, and collected in 50 ml tubes. Accutase (500 µl) 
was added to the remaining adherent MDM, and the cultures 
were incubated at 37°C/5% CO2 for 20 min, to detach the cells 
(24). The detached MDM were transferred into 50 ml tubes, and 
washed with monocyte media. The viability of both adherent and 
non-adherent MDM was ≥ 98% as determined by trypan blue 
exclusion.
Detection of cell surface Molecules
Unfractionated or fractionated MDM (adherent and non-
adherent) were washed in cold FACS buffer (PBS-containing 
0.5% BSA) and blocked in FACS buffer containing 10% normal 
goat serum. The cells were incubated for 20 min on ice with a 
cocktail containing 5–10  µg of the specific mAb or their cor-
responding isotype mAbs as controls. Cells were washed in cold 
FACS buffer and fixed in PBS-containing 2% paraformaldehyde. 
Cells were acquired on a FACSCalibur (BD Biosciences, San Jose, 
CA, USA). Data analyses were performed on the gated 7-AAD 
negative MDM (CD14+) using FlowJo 8.8.6 software (TreeStar 
Inc., Ashland, OR, USA).
cell sorting of MDM
Unfractionated MDM were harvested, pooled, and incubated 
with a mAb cocktail (CD14 FITC, CD4 PE, CD3 PerCP, 
Siglec-1 APC) on ice for 20  min. Cells were washed, and the 
pellet was resuspended in cold FACS buffer. An aliquot of the 
stained cells was acquired on a FACSCalibur before cell sort-
ing. The remaining stained cells were sorted on an LSRII (BD 
Biosciences, San Jose, CA, USA). Data analyses were performed 
on the gated CD14+MDM, using FlowJo 8.8.6 software (TreeStar 
Inc., Ashland, OR, USA). The following gating strategy was 
used: Singlets were identified and gated by their forward scatter 
height (FSC-H) and area (FSC-A) characteristics. The live cells 
within the gated singlets were identified and gated. MDM in 
the gated live population were identified by their CD14+CD3− 
characteristics. The defined CD14+CD3− cells were gated and 
further defined into a Siglec-1 versus CD4 dot plot. The cells 
segregated into two populations, Siglec-1hiCD4+MDM and 
Siglec-1LoCD4−MDM, which were subsequently collected into 
two separate tubes (Figure S1 in Supplementary Material).
hiV-1 capture and replication in 
Fractionated MDM
In our previous study (21), the MDM were infected by spinocu-
lation. In our current study, HIV-1 was gently mixed with the 
MDM cultures, with minimal perturbation, and incubated for the 
specified time-periods. The rationale for this modification was 
necessitated by our goal to maintain the MDM as non-adherent 
and adherent subsets. Although higher infectivity is achieved 
with spinoculation, this mechanical procedure would affix all 
the MDM to the plate, rendering it difficult to separate the non-
adherent MDM from their adherent counterparts. Equal numbers 
(3–5 × 105) of fractionated adherent MDM (Siglec-1LoCD4−) and 
non-adherent MDM (Siglec-1hiCD4+) were each resuspended in 
100 µl of infection media, transferred to 5 ml polystyrene tubes 
(Falcon), and incubated at 37°C/5% CO2 for 30 min followed by 
the addition of purified HIV-1 (1–5 ng p24) for an additional 3 h. 
Unadsorbed virus was removed following multiple washes (5×) 
with 1× PBS. Cells were lysed for determination of virus capture, 
and the lysates were evaluated for the presence of gag RNA by 
qRT-PCR. For evaluation of virus replication, the cell pellets were 
resuspended in 1 ml of infection media, transferred into 24-well 
flat-bottom plates, and incubated at 37°C/5% CO2. Culture 
supernatants and cells were harvested on day 4 postinfection. The 
presence of p24, indicative of HIV-1 infection, was determined in 
the two MDM subsets by flow cytomery (intracellular p24), and 
in the culture supernatants by ELISA (extracellular p24).
hiV-1 infection of Unfractionated and 
siglec-1hicD4+ Depleted MDM
Replicate wells of unfractionated MDM and Siglec-1hiCD4+ 
(non-adherent)-depleted MDM were incubated in 1  ml of 
Infection media for 30  min at 37°C/5% CO2. Purified HIV-1 
(1–5  ng p24) was added to each well and the cultures were 
incubated at 37°C/5% CO2. Cultures were harvested on day 4 
postinfection and analyzed for the presence of intracellular p24 
by flow cytometry.
coculture assays
Unfractionated MDM were exposed to HIV-1 or media for 1 h. 
Cells were fractionated into non-adherent (Siglec-1hiCD4+) and 
adherent (Siglec-1LoCD4−) MDM, and washed to remove unad-
sorbed virus. Siglec-1hiCD4+MDM were pooled and counted. 
Duplicate wells of Siglec-1LoCD4−MDM were counted as an indi-
cator for the number of Siglec-1LoCD4−MDM in each well. Equal 
numbers of HIV-1-exposed non-adherent Siglec-1hiCD4+MDM 
were cocultured with HIV-1 naive PKH-67-labeled adherent 
Siglec-1LoCD4−MDM. HIV-1 naive Siglec-1hiCD4+MDM were 
also cocultured with HIV-1 exposed PKH-67-labeled Siglec-
1LoCD4−MDM. Independent cultures of HIV-1-exposed non- 
adherent Siglec-1hiCD4+MDM and HIV-1-exposed PKH-26-
labeled adherent Siglec-1LoCD4−MDM were setup in parallel. The 
cultures were incubated for 2–3 days at 37°C/5% CO2, harvested, 
and analyzed for HIV-1 infectivity by flow cytometry.
qrT-Pcr
RNA was extracted from HIV-1-infected MDM subsets and 
the presence of gag RNA was determined by qRT-PCR as 
previously described (21, 25). Briefly, RNA was extracted from 
MDM using the RNeasy Mini Kit and Qiashredder (Qiagen) 
and the RNA was eluted in RNase free water. The qRT-PCR 
reactions were performed using the TaqMan RNA-to-Ct mas-
ter mix (Applied Biosystems) and Viia7 (Applied Biosystems). 
Reactions (50  µl) were performed in the presence of the 
master mix, 0.2 µM each of Gag forward and reverse primers, 
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Gag probe and 1× human GAPDH VIC-TAMRA (Applied 
Biosystems). Cycling parameters were 48°C for 20 min, 95°C 
for 10 min; then 45 cycles at 95°C for 15 s, and 59°C for 1 min. 
Delta Ct values were calculated to normalize the HIV-1 gag 
RNA signal as a function of the GAPDH/cellular RNA signal.
Detection of intracellular and extracellular 
hiV-1 p24 antigen
Staining for detection of intracellular p24 in HIV-1 infected 
MDM was carried out as previously described (23). Data analy-
ses were performed using FlowJo 8.8.6 software (TreeStar Inc., 
Ashland, OR, USA). The concentration of extracellular HIV gag 
p24 in the culture supernatants was determined using a HIV-1 
p24 Antigen Capture Assay kit (ABL).
rna-seq analysis of cellular genes
RNA was isolated from uninfected and HIV-1 infected MDM 
using the RNeasy Mini Kit (Qiagen) and the concentration 
was determined using Nanodrop 2000 (Thermo Scientific). 
The eluted RNA had a 260/280 of greater than 1.8. The samples 
were analyzed for quality on an Agilent BioAnalyzer and all 
samples had a RNA Integrity Number (RIN) value of greater 
than 9.5. Samples were then prepared for sequencing with the 
Clontech SMARTer system, indexed, pooled, and sequenced as 
a single 1 × 50 bp lane on an Illumina HiSeq 3000. RNA-seq 
reads were demultiplexed and aligned to the Ensembl release 
76 top-level assembly with STAR version 2.0.4b. Gene counts 
were derived from the number of uniquely aligned unambigu-
ous reads by Subread:featureCount version 1.4.5. Sequencing 
performance was assessed for total number of aligned reads, 
total number of uniquely aligned reads, and genes detected. 
The ribosomal fraction (Figure S2 in Supplementary Material), 
known junction saturation (Figure S3 in Supplementary 
Material), and read distribution over known gene models 
(Figure S4 in Supplementary Material) were quantified with 
RSeQC version 2.3.
All gene counts were then imported into the R/Bioconductor 
package EdgeR and TMM normalization size factors were 
calculated to adjust for samples for differences in library size. 
Ribosomal genes and genes not expressed in any sample greater 
than one count-per-million were excluded from further analy-
sis. The TMM size factors and the matrix of counts were then 
imported into R/Bioconductor package Limma. Performance of 
the samples was assessed with a Spearman correlation matrix. 
Sample outliers with confounding levels of variance found 
in the correlation plot were removed from further analysis 
(Figure S5 in Supplementary Material). Weighted likelihoods 
based on the observed mean-variance relationship of every 
gene and sample were then calculated for all samples with the 
voom WithQualityWeights function and gene performance was 
assessed with plots of residual standard deviation of every gene to 
their average log-count with a robustly fitted trend line of the 
residuals (Figure S6 in Supplementary Material). Generalized 
linear models were then created to test for gene level differential 
expression and the results were filtered for only those genes 
with p-values ≤0.05 and log 2 fold-changes greater than an 
absolute value of 2.
For each contrast extracted with Limma, global perturbations 
in known Gene Ontology (GO) terms and KEGG pathways 
were detected using the R/Bioconductor packages GAGE to 
test for changes in expression of the reported log 2 fold-changes 
reported by Limma in each term versus the background log 2 
fold-changes of all genes found outside the respective term. The 
R/Bioconductor package heatmap3 was used to display heatmaps 
of genes across samples for each GO terms with a p-value ≤0.05. 
The R/Bioconductor package Pathview was then used to gener-
ate annotated pathway maps on perturbed KEGG signaling and 
metabolism pathways. The logFC values reported in column B 
in Table S1 in Supplementary Material are the fold-changes as 
reported by Limma’s weighted generalized linear model likeli-
hood ratio test for the contrast of adherent and non-adherent 
MDM’s (26–29).
accession number
The accession number for the raw and processed files for the 
RNA-seq reported in this article is GEO: GSE103666.
statistical analysis
Differences were compared using the Mann-Whitney test 
(Graphpad Prism 5, Version 5.0c). A p-value of ≤0.05 was con-
sidered statistically significant. Statistical analyses for the RNA-
Seq data were performed as mentioned above in the RNA-Seq 
analysis of cellular genes.
resUlTs
M-csF-Derived MDM comprised Two 
subsets-siglec-1hicD4+MDM and  
siglec-1locD4−MDM
We have previously demonstrated that blocking Siglec-1 recep-
tor on MDM resulted in 90–95% inhibition of HIV-1 infection, 
whereas blocking CD4 receptor inhibited infection in 50–55% 
of MDM (21). Thus, we investigated the possible existence of 
subsets of MDM that coexpressed varying amounts of Siglec-1 
and CD4. Both adherent and non-adherent cells were evident 
in the M-CSF-derived MDM cultures. Flow cytometric analysis 
of the combined adherent and non-adherent fractions showed 
that M-CSF-derived MDM, irrespective of the donor, segregated 
into two distinct subsets: Siglec-1hiCD4+ and Siglec-1LoCD4− 
(Figure 1A). Two notable observations were made. First, within 
the MDM cultures in all nine donors, Siglec-1hiCD4+MDM 
comprised a lower proportion of cells (0.6–22.7%) compared 
to Siglec-1LoCD4−MDM (62.8–94.9%). Second, the proportion 
of Siglec-1hiCD4+MDM varied among donors (Table  1). Both 
MDM subsets expressed similar frequencies of CD14, and were 
negative for CD3, implying the absence of T-cell contamination 
(Figure 1B).
Since the main goal of this study was to individually evaluate 
the two different MDM subsets for HIV-1 infection, we utilized 
two different methods (cell sorting and cell fractionation) to 
FigUre 1 | Monocyte-derived macrophage (MDM) segregate into two distinct subsets: Non-adherent Siglec-1hiCD4+MDM and adherent Siglec-1LoCD4−MDM. 
Triplicate wells of primary human monocytes from nine human immunodeficiency virus (HIV)-seronegative donors (#048, #130, #170, #008, #002, #202, #132, 
#124, and #040) were differentiated into MDM following in vitro culture in M-CSF media for 5 days. Cultures were harvested, stained, and analyzed by flow 
cytometry. (a) Plots show percentage of Siglec-1hiCD4+MDM and Siglec-1LoCD4−MDM within the gated CD14+ cells. A representative plot of one of the two 
independent experiments is shown. (B) Plots show that gated CD14+ cells are not contaminated with CD3+ T cells. (c,D) In vitro cultures of M-CSF-derived  
MDM contain adherent and non-adherent MDM. (c) Adherent and non-adherent MDM were pooled, stained, and the gated CD14+ cells were sorted into 
Siglec-1hiCD4+MDM and Siglec-1LoCD4−MDM. (D) Non-adherent MDM were separated from adherent MDM following repeated washing with media. Adherent  
MDM were detached with Accutase. Both fractions were washed, stained, and the gated CD14+ cells were analyzed separately for the expression of Siglec-1 and 
CD4. Plots show that non-adherent fraction represented the Siglec-1hiCD4+MDM subset, whereas the adherent fraction comprised the Siglec-1LoCD4−MDM subset. 
(e) Histograms show the expression of CCR5 and CD163 on the gated Siglec-1LoCD4−MDM (blue) and Siglec-1hiCD4+MDM (red) subsets. Values in the histograms 
denote the mean fluorescent intensity (MFI) of the specific receptors for each of the subsets. Each experiment was done twice in triplicate and the data from one of 
the two experiments are shown.
TaBle 1 | Mean fluorescence intensity (MFI) of Siglec-1 for Siglec-1hiCD4+MDM 
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separate the two MDM subsets. For cell sorting, the MDM were 
stained with a mAb cocktail and subjected to sorting by flow 
cytometry (Figure 1C). MDM were sorted into the two subsets 
(Siglec-1hiCD4+ and Siglec-1LoCD4−) with 89–90% purity. The 
second method employed was cell fractionation (Figure 1D). 
The fractionation procedure was based on the differential 
adherence characteristics of the two different subsets of MDM. 
Although, both procedures (Figures  1C,D) yielded highly 
enriched and pure subsets, the fractionation procedure was 
simple, inexpensive, gentle, fast, and circumvented the possible 
effects of antibody exposure and subsequent mechanical cell 
FigUre 2 | Presence of Siglec-1hiCD4+MDM dampens the degree of human immunodeficiency virus type 1 (HIV-1) infection. Monocytes from three donors were 
differentiated into monocyte-derived macrophage (MDM) with M-CSF media. (a) Panels show plots of unfractionated MDM and their Siglec-1hiCD4+MDM-depleted 
counterparts. (B) Unfractionated MDM and Siglec-1hiCD4+MDM-depleted cultures were infected with purified HIV-1 (BaL, JRFL, or US-1). Cells were harvested  
on day 3 postinfection, stained, and analyzed by flow cytometry. Panels show plots of HIV-1 infection in the unfractionated MDM cultures and in their Siglec-
1hiCD4+MDM-depleted counterparts. Values in the upper right quadrant(s) represent the percentage of infected MDM. Data represent one of the triplicate  
wells from one of two independent experiments. (c) Bar graph is derived from the experiment performed in Figure 2B and includes the data from the  
triplicate wells of two independent experiments and shows the% p24+MDM (mean ± SD) in unfractionated MDM (filled bars) or in the  
Siglec-1hiCD4+MDM-depleted MDM (open bars) following infection with HIV-1. Significance is indicated by *p ≤ 0.05.
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sorting. With all donors, routine flow cytometric analyses of the 
fractionated MDM subsets consistently revealed that the non-
adherent MDM represented the Siglec-1hiCD4+MDM, whereas 
the adherent MDM comprised the Siglec-1LoCD4−MDM (data 
not shown). Therefore, we utilized the fractionation procedure 
for the experiments described in this study. Evaluation of HIV-1 
coreceptor (CCR5) revealed that the expression of CCR5 was 
similar on both subsets, whereas the scavenger receptor (CD163) 
was only coexpressed on Siglec-1hiCD4+MDM (Figure  1E). 
These data reveal the existence of two subsets of M-CSF-
derived MDM; a small subset of Siglec-1hiCD4+CD163+MDM 
(non-adherent), with a relatively high expression of molecules 
that are associated with HIV-1 infection, and a more prominent 
subset of Siglec-1LoCD4−CD163−MDM (adherent), with a 
relatively lower expression of Siglec-1, and devoid of CD4 and 
CD163.
siglec-1hicD4+MDM Dampens the  
Degree of hiV-1 infectivity
The presence of relatively high levels of molecules that are 
associated with HIV-1 infection on the M-CSF-derived MDM 
subset led us to hypothesize that the non-adherent Siglec-
1hiCD4+MDM would be highly permissive to HIV-1 infection. 
To address this hypothesis, we evaluated the degree of HIV-1 
infection in unfractionated and Siglec-1hiCD4+ depleted MDM. 
We utilized the fractionation procedure mentioned above in 
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three donors (#170, #130, and #002), to remove non-adherent 
Siglec-1hiCD4+MDM from the adherent MDM population. 
The efficiency of the fractionation procedure to deplete Siglec-
1hiCD4+MDM from the cultures was confirmed by flow cytom-
etry (Figure  2A). Unfractionated MDM and Siglec-1hiCD4+ 
depleted MDM from multiple donors were infected with three 
different HIV-1 subtype B purified viruses (BaL, JRFL, and US-1). 
The degree of infectivity was variable among the donors with 
each of the viruses. Surprisingly, with all the viruses and in all 
the donors, HIV-1 infection was consistently and significantly 
higher (p  ≤  0.05) in Siglec-1hiCD4+MDM-depleted cultures 
compared to unfractionated MDM cultures, (Figures  2B,C). 
Our data demonstrate that in an in vitro infection set-up, Siglec-
1hiCD4+MDM dampened the effect on the degree of HIV-1 
infection. This suggests that in vitro, the outcome of HIV-1 infec-
tion may be related to the percentage of Siglec-1hiCD4+MDM 
in the well.
siglec-1hicD4+MDM are efficient at hiV-1 
capture but less Permissive to infection
We sought to further investigate the interaction of the two 
MDM subsets with HIV-1. In this regard, we evaluated if the 
two subsets exhibited differences in their ability to capture 
virus, and/or support infection. Equal numbers of fraction-
ated Siglec-1LoCD4−MDM and Siglec-1hiCD4+MDM from 
different donors were exposed to three different subtype B 
HIV-1 (BaL, US-1, JRFL). First, we evaluated HIV-1 capture 
by the two subsets (Figure 3A). This was determined by the 
presence of gag RNA using qRT-PCR. The cells were harvested 
at 3 h postinfection. RNA was isolated from cell lysates and 
qRT-PCR was performed. The data are plotted as ΔCt values. 
A low ΔCt value represents a higher amount of viral RNA. 
As shown in Figure  3A, HIV-1 capture of all three viruses 
was significantly higher in the Siglec-1hiCD4+MDM (lower 
Ct value), compared to Siglec-1LoCD4−MDM (higher Ct 
value) in all three donors. Next, we evaluated HIV-1 infec-
tion at day 4 postinfection. HIV-1 infection was determined 
by the presence of intracellular p24 using flow cytometry 
(Figures  3B,C), as well as the presence of extracellular p24 
in the supernatants using ELISA (Figure  3D). Interestingly, 
in all the donors and with all three viruses, the percentage 
of p24 positive MDM was significantly higher in the Siglec-
1LoCD4−MDM compared to the Siglec-1hiCD4+MDM subset 
(Figures  3B,C). Parallel determination of extracellular p24 
in the culture supernatants also revealed significantly higher 
levels in Siglec-1LoCD4−MDM cultures, than in the Siglec-
1hiCD4+MDM cultures (Figure 3D). Collectively, these results 
suggest that although Siglec-1LoCD4−MDM are less efficient 
at HIV-1 capture than Siglec-1hiCD4+MDM, they are more 
permissive to HIV-1 infection.
Although the fractionated Siglec-1LoCD4−MDM were initially 
devoid of Siglec-1hiCD4+MDM and were cultured as a relatively 
pure subset, we detected the presence of Siglec-1hiCD4+MDM 
at day 4 postinfection in the uninfected controls (Figure 3E), as 
well as in the infected Siglec-1LoCD4−MDM cultures (Figure 3F). 
This is indicative of macrophage plasticity, and suggests that 
Siglec-1LoCD4−MDM are the precursors of Siglec-1hiCD4+MDM. 
Notably, HIV-1 infection was mainly evidenced in the gated 
Siglec-1LoCD4−MDM (Figure  3G), but not in the Siglec-
1hiCD4+MDM (Figure 3H).
siglec-1hicD4+MDM although Poorly 
Permissive Do Transfer hiV-1 to siglec-1lo 
cD4−MDM
Despite increased HIV-1 capture (Figure  3A), virus replica-
tion was restricted in Siglec-1hiCD4+MDM (Figures  3B–D). 
It may be possible that Siglec-1hiCD4+MDM only captured 
and sequestered HIV-1. However, it is equally plausible that 
Siglec-1hiCD4+MDM facilitated transfer of captured virions to 
other cells. To evaluate this, we exposed unfractionated M-CSF-
derived MDM to BaL for 1 h. The HIV-1-exposed MDM were 
fractionated into non-adherent and adherent populations. 
Phenotypic analysis of aliquots of the non-adherent and adher-
ent fractions confirmed that they were Siglec-1hiCD4+MDM and 
Siglec-1LoCD4−MDM, respectively (data not shown). The HIV-
1-exposed Siglec-1LoCD4−MDM were labeled with PKH-26, 
a cell membrane-labeling dye. The HIV-1-exposed MDM subsets 
were cultured independently, and served as infection controls 
(Figure 4A,B). Although HIV-1 infection was detected in both 
subsets, it was higher in the Siglec-1LoCD4−MDM compared 
to the Siglec-1hiCD4+MDM in all three donors (Figure 4A,B). 
These data further highlighted that the Siglec-1hiCD4+MDM 
subset were less permissive to HIV-1 infection and are consistent 
with the results shown in Figures 3B–D.
To evaluate whether the HIV-1-exposed MDM subsets 
exhibited differences in their ability to transfer HIV-1, Siglec-
1hiCD4+MDM from the three donors that were exposed to BaL 
were cocultured for 3 days with uninfected Siglec-1LoCD4−MDM 
that were labeled with PKH-67 to distinguish them from Siglec-
1hiCD4+MDM or from Siglec-1hiCD4+MDM that may have 
down-regulated Siglec-1 and CD4 during infection. As shown 
in Figure  4C, HIV-1 infection (3.85, 10.3, and 8.66%, respec-
tively) was evident in the PKH-67-labeled Siglec-1LoCD4−MDM 
in all three donors. This indicated that the HIV-exposed 
Siglec-1hiCD4+MDM transferred virus to the uninfected PKH- 
67-labeled Siglec-1LoCD4−MDM.
In parallel, uninfected Siglec-1hiCD4+MDM were cocultured 
with HIV-exposed Siglec-1LoCD4−MDM that were labeled 
with PKH-26 (Figure 4D). The coculture resulted in decreased 
infection (Figures  4B,D), suggestive of an inherent ability of 
Siglec-1hiCD4+MDM to restrict HIV-1 infection. These results are 
consistent with the data shown in Figure 2. The HIV-1-infected 
cells were largely restricted within the HIV-exposed PKH- 
26-labeled Siglec-1LoCD4−MDM.
Differential expression of hiV-1 restriction 
Factors and cytokine genes in siglec-1hi 
cD4+MDM and siglec-1locD4−MDM
The expression of cellular restriction factors and cytokine 
genes that affect HIV-1 infection in macrophages have been 
FigUre 3 | Human immunodeficiency virus type 1 (HIV-1) infection is lower in Siglec-1hiCD4+MDM despite higher virus capture. Equal numbers (3 × 105 cells) of 
Siglec-1hiCD4+MDM and Siglec-1LoCD4−MDM from three HIV-seronegative donors (#130, #170, #132) were incubated with HIV-1 (BaL, JRFL, or US-1) for 3 h at 
37°C/5% CO2. (a) Cell lysates were subjected to qRT-PCR to detect gag RNA transcripts, indicative of virus capture. Uninfected cell lysates were negative for gag 
RNA transcripts (not shown). Bar graphs show the delta Ct (normalized) gag RNA in Siglec-1hiCD4+MDM (red bars) and Siglec-1LoCD4−MDM (blue bars) for each 
donor and with each virus. Data are representative of three independent experiments and show the mean values (***p ≤ 0.001). (B,c) Siglec-1hiCD4+MDM and 
Siglec-1LoCD4−MDM were infected with HIV-1. Cultures were harvested on day 4 postinfection, washed, stained, and analyzed for the presence of intracellular p24 
by flow cytometry. (B) Panels show plots of HIV-1 infection in gated Siglec-1hiCD4+MDM and Siglec-1LoCD4−MDM from a representative donor. (c) Bar graph shows % 
p24+MDM of triplicate wells of three independent experiments (mean ± SD; *p ≤ 0.05) in Siglec-1LoCD4−MDM (blue bars) and in the Siglec-1hiCD4+MDM (red bars) 
following infection with US-1, BaL, or JRFL. (D) Supernatants from cultures of HIV-1-infected Siglec-1hiCD4+MDM and Siglec-1LoCD4−MDM were harvested on day 
4 postinfection, and analyzed by ELISA for the presence of extracellular p24. Bar graphs show the p24 concentration of triplicate wells of two independent 
experiments (mean ± SD; *p ≤ 0.05) in the supernatants of HIV-1-infected Siglec-1LoCD4−MDM (blue bars) and Siglec-1hiCD4+MDM (red bars) for each donor and 
with each virus. (e,F) Siglec-1LoCD4−MDM (#130) were left uninfected, or (F) were infected with HIV-1. Plots show the presence of Siglec-1hiCD4+MDM both in (e) 
the uninfected Siglec-1LoCD4−MDM cultures and in (F) their HIV-1-infected Siglec-1LoCD4−MDM cultures. (g,h) The HIV-1-infected monocyte-derived macrophage 
(MDM) described in (F) were analyzed for localization of HIV-1 on the basis of their Siglec-1LoCD4−MDM versus Siglec-1hiCD4+MDM phenotype. Panels show that 
the presence of HIV-1 infection only in (g) gated Siglec-1LoCD4−MDM and not in the (h) gated Siglec-1hiCD4+MDM. Values in the upper right quadrant(s) represent 
the percentage of infected MDM. A representative plot of three independent experiments is shown.
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previously described (30–39). To gain more insight into the 
possible reasons for the differential permissivity to HIV-1 
infection observed in our study, we examined M-CSF-derived 
MDM from three donors that were fractionated into Siglec-
1LoCD4−MDM and Siglec-1hiCD4+MDM, in the absence or 
presence of HIV-1 for 3  h. The expression levels of cellular 
restriction factors and cytokine-related genes were analyzed by 
RNA-Seq (Figure 5; Table S1 in Supplementary Material). One 
of the donors, #130 was inconsistent in the data compared to 
the other two donors (Figure S5 in Supplementary Material) and 
therefore the data from #130 was removed. Known genes for 
cellular restriction factors and cytokines that were considered 
significantly different in the two subsets, Siglec-1LoCD4−MDM 
and Siglec-1hiCD4+MDM were chosen. Of these, the 23 genes 
FigUre 4 | Siglec-1hiCD4+MDM transfer human immunodeficiency virus type 1 (HIV-1) to Siglec-1LoCD4−MDM. (a) M-CSF-derived monocyte-derived macrophage 
(MDM) from three donors were incubated with media or with HIV-1 (BaL) for 1 h at 37°C/5% CO2. Cells were washed and fractionated into Siglec-1hiCD4+MDM  
and Siglec-1LoCD4−MDM. The infected Siglec-1LoCD4−MDM were subsequently labeled with PKH-26. Both subsets were cultured at 37°C/5% CO2. (a) Plots  
show the percentage of infected cells at 3 days postculture in the infected Siglec-1hiCD4+MDM and (B) the infected Siglec-1LoCD4−MDM. (c) HIV-1 exposed 
Siglec-1hiCD4+MDM were cocultured with PKH-67-labeled uninfected Siglec-1LoCD4−MDM. Plots show evidence of HIV-1 infection in both the Siglec- 
1hiCD4+MDM and the PKH-67-labeled Siglec-1LoCD4−MDM. (D) In parallel, PKH-26-labeled HIV-1-exposed Siglec-1LoCD4−MDM were cocultured with  
uninfected Siglec-1hiCD4+MDM. Plots show evidence of HIV-1 infection mostly in the PKH-26-labeled Siglec-1LoCD4−MDM.
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selected were within the top 7,500 differentially expressed genes. 
We observed a trend of higher cellular restriction factor gene 
expression including viperin (RSAD2), SLFN11, IFI16, TREX1, 
APOBEC family, tetherin (BST2), TRIM5, and TRIM22 in the 
non-adherent Siglec-1hiCD4+MDM compared to the adherent 
Siglec-1LoCD4−MDM. This pattern of differential expression 
was observed in the uninfected subsets and remained in the 
HIV-1 infected Siglec-1LoCD4−MDM and Siglec-1hiCD4+MDM. 
Viperin (RSAD2), TRIM22, IFI16, and APOBEC3D were all 
within the top 200 differentially expressed genes. Surprisingly, 
the expression of SAMHD1 (40–42), SERINC5, and SERINC3 
(43, 44), was higher in the HIV-1 permissive Siglec-1LoCD4−MDM 
compared to the less permissive Siglec-1hiCD4+MDM, despite 
their innate antiviral properties. Cyclin-dependent kinases 
(CDK1, CDK2) which phosphorylate SAMHD1 and impair its 
HIV-restriction ability (45–47), showed a higher expression 
in Siglec-1LoCD4−MDM compared to Siglec-1hiCD4+MDM. In 
addition to restriction factors, cytokines such as IL-12 and IL-13 
also influence HIV-1 replication in MDM (32, 33, 48). Expression 
of the genes for the IL-12R and IL-13 were higher in the HIV-1-
restrictive Siglec-1hiCD4+MDM. This subset also showed higher 
gene expression for insulin growth factor-1 (IGF-1), which has 
been previously demonstrated to be present in activated alveolar 
macrophages and to inhibit HIV-1 replication in cultured cord 
blood mononuclear cells as well as in chronically HIV-1 infected 
U937 cells (30, 49). These trends in gene expression profiles show 
that several factors that restrict HIV-1 infectivity were more 
highly expressed in the non-adherent Siglec-1hiCD4+MDM com-
pared to the adherent Siglec-1LoCD4−MDM and is suggestive of 
the restricted HIV-1 infection that we observed.
DiscUssiOn
Macrophages are important targets for HIV-1 infection (50). 
In a recent study, it was shown that macrophages were capable 
of sustaining HIV-1 infection in the absence of T  cells (4). In 
FigUre 5 | Heat map of expression of human immunodeficiency virus type 1 (HIV-1) restriction factors and cytokine genes in uninfected and HIV-1-infected 
Siglec-1hiCD4+MDM and Siglec-1LoCD4−MDM. M-CSF-derived monocyte-derived macrophage (MDM) from two donors were fractionated into Siglec-1hiCD4+MDM 
and Siglec-1LoCD4−MDM. The MDM subsets were incubated with media or with HIV-1 (BaL) for 3 h at 37°C/5% CO2. The expression levels of cellular restriction 
factors, insulin growth factor-1 (IGF-1), IL-13, and IL-12-related genes were analyzed by RNA-Seq. Relative expression levels of HIV-1 restriction genes are shown 
for uninfected and infected Siglec-1hiCD4+MDM and Siglec-1LoCD4−MDM samples with a self-clustering heatmap generated by the R/CRAN package heatmap3. 
Samples and genes are clustered by their respective expression profiles and every row is rescaled to have a mean of zero and standard deviation of 0 in order to 
illustrate relative expression changes across samples on a scale similar to log 2 fold-change. Blue indicates low expression, and red indicates high expression.
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compartments such as the central nervous system, macrophages 
are the principal targets for HIV-1 (51). HIV-1-infected tissue-
resident macrophages are largely resistant to the cytopathic 
effects of the virus. Unlike HIV-1-infected CD4+ T cells which 
are progressively depleted by mechanisms including apoptosis, 
infected macrophages are largely resistant to apoptosis (52). As 
a result, macrophages can harbor HIV-1 for extended periods 
(53–55), making them a major factor in the establishment of 
the viral reservoir (56). Macrophages are central to the innate 
immune response, and may be important in the control of oppor-
tunistic infections. It is therefore conceivable that perturbation of 
macrophage responses and functions as a result of HIV-1 
infection may impair innate immune control and allow for the 
onset of opportunistic infections.
In the present study, MDM were used. However, macrophages 
are not all derived from circulating monocytes. Indeed, 
accumulating evidence suggests the presence of resident mac-
rophages in several tissues that self-renew locally throughout 
adult life, independently of circulating monocytes (10, 11, 
13, 57). Nonetheless, irrespective of the donors tested in our study, 
the MDM segregated into two distinct subsets; non-adherent and 
adherent. The two subsets exhibited a differential expression of 
cellular receptors associated with HIV-1 such as Siglec-1, CD4, 
and CD163. The non-adherent MDM were Siglec-1hiCD4+ and the 
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adherent MDM were Siglec-1LoCD4−. The non-adherent Siglec-
1hiCD4+MDM comprised the smaller subset and varied among 
the donors. Although both subsets expressed comparable levels 
of CD14 and CCR5, only the non-adherent Siglec-1hiCD4+MDM 
expressed CD163. Interestingly, in  vitro culture of fractionated 
adherent Siglec-1LoCD4−MDM gave rise to non-adherent Siglec-
1hiCD4+MDM, suggesting that Siglec-1LoCD4−MDM may be the 
precursors of Siglec-1hiCD4+MDM. This highlights the plasticity 
of MDM and is in line with a previous observation that showed 
adherent interstitial lung macrophages as the precursors of non-
adherent alveolar macrophages (15).
We found that significantly more HIV-1 was captured by the 
non-adherent Siglec-1hiCD4+MDM than their adherent Siglec-
1LoCD4−MDM counterparts. We and others have reported that 
Siglec-1 is an attachment molecule for HIV-1 (20, 21). Therefore, 
it is probable that the higher expression of HIV-1 associated 
cellular receptors on Siglec-1hiCD4+MDM may have resulted 
in a propensity for more efficient virus capture. Interestingly, 
although more HIV-1 was captured by the non-adherent Siglec-
1hiCD4+MDM, infection was significantly restricted in these 
cells. Indeed, irrespective of donor, HIV-1 infection with BaL, 
US-1, or JRFL was consistently lower in the non-adherent Siglec-
1hiCD4+MDM, than in the adherent Siglec-1LoCD4−MDM.
Our observation that HIV-1 permissiveness was subset 
related has been reported in other cell types. In HIV-1-infected 
patients, evidence of HIV-1 infection is detected in only a very 
small number of monocytes (54). Characterization of monocyte 
subsets revealed that CD16+ monocytes were more permissive 
to HIV-1 than CD16− monocytes (58, 59), demonstrating that 
CD16+ monocytes are the HIV-1 permissive monocyte subset. 
In the lungs of HIV-1 infected subjects, HIV-1 preferentially 
localized in a subset of small alveolar macrophages (14). Among 
CD4+ T cells, CCR4+CCR6− T cells and CXCR3+CCR6+ T cells 
are highly permissive to both R5 and X4 HIV-1 viruses, whereas 
CXCR3+CCR6− T cells are resistant to both R5 or X4 viruses (60).
Our data highlighted interesting differences between the 
non-adherent Siglec-1hiCD4+MDM and the adherent Siglec-
1LoCD4−MDM in their capacities to transfer HIV-1 to other 
MDM. Non-adherent Siglec-1hiCD4+MDM which were more 
restrictive to HIV-1 infection transferred virus to adherent 
Siglec-1LoCD4−MDM. This suggests that Siglec-1hiCD4+MDM 
and Siglec-1LoCD4−MDM may have distinct roles or functions 
in the context of HIV-1 infection. The restrictive phenotype of 
non-adherent Siglec-1hiCD4+MDM suggests that these cells 
primarily capture HIV-1 and could transfer the captured virus to 
other cells. In contrast, the permissive phenotype of the adherent 
Siglec-1LoCD4−MDM suggests these as the preferential subset 
for HIV-1 infection. Indeed, the higher expression of integrins/
adhesion molecules by the non-adherent Siglec-1hiCD4+MDM 
(LFA-1, ICAM-1, ICAM-2, ICAM-3, and ICAM-5) further sug-
gest that they probably interact more efficiently with other cells 
compared to Siglec-1LoCD4−MDM.
It has been previously demonstrated that differences in HIV-1 
permissiveness has been related to the differential expression 
of intrinsic anti-HIV-1 cellular factors (61–63). We examined 
uninfected and HIV-1-infected Siglec-1hiCD4+MDM and 
Siglec-1LoCD4−MDM, and compared the expression of several 
well-characterized cellular factors that restrict HIV-1 infection. 
The non-adherent Siglec-1hiCD4+MDM expressed higher levels 
of several restriction factor genes that affect HIV-1 replication 
and release of infectious virus, even prior to HIV-1 exposure. 
While some genes directly inhibit HIV-1, other genes may induce 
innate factors that restrict HIV-1 infection. The higher expression 
of TRIM22 (37, 64), BST2 (tetherin) (65–67), APOBEC (68–70), 
and SLFN11 (71–73), by non-adherent Siglec-1hiCD4+MDM 
indicated that these MDM may be more restrictive to HIV-1 
infection. The higher expression of the cyclin-dependent kinases 
in Siglec-1LoCD4−MDM may also explain the increased HIV-1 
infectivity in these MDM despite their increased SAMHD1 
expression profile. In addition, IL-12R1 and IL-12R2, IL-13, 
and IGF-1 genes were upregulated in the non-adherent Siglec-
1hiCD4+MDM. Since these genes have been reported to inhibit 
viral replication, we speculate that they may contribute to the 
restrictive permissivity observed with the non-adherent Siglec-
1hiCD4+MDM. Other methods including qPCR will be employed 
to confirm these data. This differential pattern of HIV-1 restric-
tive genes expression was maintained postinfection.
Our study identified two macrophage subsets that interact 
differentially with HIV-1. Siglec-1hiCD4+MDM, an HIV-1 res-
trictive subset, captures and transfers virus to macrophages. 
Siglec-1LoCD4−MDM on the other hand, are highly permissive 
to HIV-1 infection, and may not readily transfer virus to 
macrophages. Should interventions be aimed at the permissive 
macrophage subset, or should it be focused on the restric-
tive macrophage subset that capture and facilitate transfer 
of virus to other cells? This highlights the complex role of 
macrophages in HIV-1 pathogenesis. Our data suggest that 
interventions should aim to block interactions between HIV-1 
and macrophages.
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